Pharmaceutical cocrystal: a game changing approach for the administration of old drugs in new crystalline form

References

• Kavanagh ON, Croker DM, Walker GM, et al. Pharmaceutical cocrystals: from serendipity to design to application. Drug Discov Today. 2019;24(3):796–804.
   PubMed Web of Science ®Google Scholar
• Yousef MAE, Vangala VR. Pharmaceutical cocrystals: molecules, crystals, formulations, medicines. Cryst Growth Des. 2019;19(12):7420–7438.
   Web of Science ®Google Scholar
• Panzade PS, Shendarkar GR. Pharmaceutical cocrystal: an antique and multifaceted approach. Curr Drug Deliv. 2017;14(8):1097–1105.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Aller M, Guillarme D, Veuthey JL, et al. Strategies for formulating and delivering poorly water-soluble drugs. J Drug Deliv Sci Technol. 2015;30:342–351.
   Web of Science ®Google Scholar
• Horstman EM, Bertke JA, Kim EH, et al. Crystallization and characterization of cocrystals of piroxicam and 2,5-dihydroxybenzoic acid. CrystEngComm. 2015;17(28):5299–5306.
   Web of Science ®Google Scholar
• Stoler E, Warner JC. Non-covalent derivatives: cocrystals and eutectics. Molecules. 2015;20(8):14833–14848.
   PubMed Web of Science ®Google Scholar
• El-Gizawy SA, Osman MA, Arafa MF, et al. Aerosil as a novel co-crystal co-former for improving the dissolution rate of hydrochlorothiazide. Int J Pharm. 2015;478(2):773–778.
   PubMedGoogle Scholar
• Shaikh R, Singh R, Walker GM, et al. Pharmaceutical cocrystal drug products: an outlook on product development. Trends Pharmacol Sci. 2018;39(12):1033–1048.
   PubMed Web of Science ®Google Scholar
• Sai Gouthami K, Kumar D, Thipparaboina R, et al. Can crystal engineering be as beneficial as micronisation and overcome its pitfalls? A case study with cilostazol. Int J Pharm. 2015;491(1–2):26–34.
   PubMedGoogle Scholar
• Serrano DR, Persoons TD, Arcy DM, et al. Modelling and shadowgraph imaging of cocrystal dissolution and assessment of in vitro antimicrobial activity for sulfadimidine/4-aminosalicylic acid cocrystals. Eur J Pharm Sci. 2016;89:125–136.
   PubMed Web of Science ®Google Scholar
• Ullah M, Hussain I, Sun CC. The development of carbamazepine-succinic acid cocrystal tablet formulations with improved in vitro and in vivo performance. Drug Dev Ind Pharm. 2016;42(6):969–976.
   PubMed Web of Science ®Google Scholar
• US Food and Drug Administration. Guidance for Industry: Regulatory Classification of Pharmaceutical Co-crystals. [cited 2020 Apr 10]. Available from: https://www.fda.gov/media/81824/download
   Google Scholar
• Thakuria R, Delori A, Jones W, et al. Pharmaceutical cocrystals and poorly soluble drugs. Int J Pharm. 2013;453(1):101–125.
   PubMed Web of Science ®Google Scholar
• Samsodien H, Bapoo M, Doms T, et al. FTIR, dissolution and anti-viral activity of nevirapine co-crystals. Pharm Anal Acta. 2017;8(9):1000561.
   Google Scholar
• Marques MRC, Choo Q, Ashtikar M, et al. Nanomedicines – tiny particles and big challenges. Adv Drug Deliv Rev. 2019;151–152:23–43.
   PubMed Web of Science ®Google Scholar
• Baghel S, Cathcart H, O'Reilly NJ. Polymeric amorphous solid dispersions: a review of amorphization, crystallization, stabilization, solid-state characterization, and aqueous solubilization of biopharmaceutical classification system class II drugs. J Pharm Sci. 2016;105(9):2527–2544.
   PubMed Web of Science ®Google Scholar
• Kuminek G, Cao F, Bahia de Oliveira da Rocha A, et al. Cocrystals to facilitate delivery of poorly soluble compounds beyond-rule-of-5. Adv Drug Deliv Rev. 2016;101:143–166.
   PubMed Web of Science ®Google Scholar
• Babu NJ, Sanphui P, Nangia A. Crystal engineering of stable temozolomide cocrystals. Chem Asian J. 2012;7(10):2274–2285.
   PubMed Web of Science ®Google Scholar
• Kale DP, Zode SS, Bansal AK. Challenges in translational development of pharmaceutical cocrystals. J Pharm Sci. 2017;106(2):457–470.
   PubMed Web of Science ®Google Scholar
• Vemuri VD, Lankalapalli S. Insight into concept and progress on pharmaceutical co-crystals: an overview. Indian J Pharm Educ Res. 2019;53(4s):s522–s538.
   Google Scholar
• Salas-Zúñiga R, Rodríguez-Ruiz C, Höpfl H, et al. Dissolution advantage of nitazoxanide cocrystals in the presence of cellulosic polymers. Pharmaceutics. 2019;12(1):23.
   Web of Science ®Google Scholar
• Dai XL, Chen JM, Lu TB. Pharmaceutical cocrystallization: an effective approach to modulate the physicochemical properties of solid-state drugs. CrystEngComm. 2018;20(36):5292–5316.
   Web of Science ®Google Scholar
• Dos Santos JAB, Chaves Júnior JV, de Araújo Batista RS, et al. Preparation, physicochemical characterization and solubility evaluation of pharmaceutical cocrystals of cinnamic acid. J Therm Anal Calorim. 2020.DOI:10.1007/s10973-020-09708-6
   Google Scholar
• Kumar S, Nanda A. Approaches to design of pharmaceutical cocrystals: a review. Mol Cryst Liq Cryst. 2018;667(1):54–77.
   Web of Science ®Google Scholar
• Sanjay A, Manohar D, Bhanudas S. Pharmaceutical cocrystallization: a review. J Adv Pharm Educ Res. 2014;4(4):388–396.
   Google Scholar
• Perlovich GL, Manin AN. Design of pharmaceutical cocrystals for drug solubility improvement. Russ J Gen Chem. 2014;84(2):407–414.
   Web of Science ®Google Scholar
• Najar AA, Azim Y. Pharmaceutical co-crystals: a new paradigm of crystal engineering. J Indian Inst Sci. 2014;94(1):45–67.
   Web of Science ®Google Scholar
• Karimi-Jafari M, Padrela L, Walker GM, et al. Creating cocrystals: a review of pharmaceutical cocrystal preparation routes and applications. Cryst Growth Des. 2018;18(10):6370–6387.
   Web of Science ®Google Scholar
• Zhou J, Li L, Zhang H, et al. Crystal structures, dissolution and pharmacokinetic study on a novel phosphodiesterase-4 inhibitor chlorbipram cocrystals. Int J Pharm. 2020;576:118984.
   PubMedGoogle Scholar
• Merah A, Abidi A, Chaffai N, et al. Role of hydroxypropylmethylcellulose (HPMC 4000) in the protection of the polymorphs of Piroxicam extended release tablets. Arab J Chem. 2017;10:S1243–S1253.
   Web of Science ®Google Scholar
• Koide T, Takeuchi Y, Otaki T, et al. Quantification of a cocrystal and its dissociated compounds in solid dosage form using transmission Raman spectroscopy. J Pharm Biomed Anal. 2020;177:112886.
   PubMed Web of Science ®Google Scholar
• Walsh D, Serrano DR, Worku ZA, et al. Engineering of pharmaceutical cocrystals in an excipient matrix: spray drying versus hot melt extrusion. Int J Pharm. 2018;551(1–2):241–256.
   PubMedGoogle Scholar
• Ren S, Liu M, Hong C, et al. The effects of pH, surfactant, ion concentration, coformer, and molecular arrangement on the solubility behavior of myricetin cocrystals. Acta Pharm Sin B. 2019;9(1):59–73.
   PubMed Web of Science ®Google Scholar
• Bhardwaj S, Lipert M, Bak A. Mitigating cocrystal physical stability liabilities in preclinical formulations. J Pharm Sci. 2017;106(1):31–38.
   PubMed Web of Science ®Google Scholar
• Almansa C, Frampton CS, Vela JM, et al. Co-crystals as a new approach to multimodal analgesia and the treatment of pain. J Pain Res. 2019;12:2679–2689.
   PubMed Web of Science ®Google Scholar
• Panzade P, Shendarkar G, Shaikh S, et al. Pharmaceutical cocrystal of piroxicam: design, formulation and evaluation. Adv Pharm Bull. 2017;7(3):399–408.
   PubMed Web of Science ®Google Scholar
• Panzade P, Shendarkar G. Design and preparation of zaltoprofen-nicotinamide pharmaceutical cocrystals via liquid assisted grinding method. Turk J Pharm Sci. 2019;53(4):669–676.
   Google Scholar
• Daurio D, Medina C, Saw R, et al. Application of twin screw extrusion in the manufacture of cocrystals. Part I: four case studies. Pharmaceutics. 2011;3(3):582–600.
   PubMedGoogle Scholar
• Rehder S, Peter N, Christensen A, et al. High-shear granulation as a manufacturing method for cocrystal granules. Eur J Pharm Biopharm. 2013;85(3 Pt B):1019–1030.
   PubMed Web of Science ®Google Scholar
• Chow SF, Chen M, Shi L, et al. Simultaneously improving the mechanical properties, dissolution performance, and hygroscopicity of ibuprofen and flurbiprofen by cocrystallization with nicotinamide. Pharm Res. 2012;29(7):1854–1865.
   PubMed Web of Science ®Google Scholar
• Holaň J, Ridvan L, Billot P, et al. Design of co-crystallization processes with regard to particle size distribution. Chem Eng Sci. 2015;128:36–43.
   Web of Science ®Google Scholar
• Kudo S, Takiyama H. Production method of carbamazepine/saccharin cocrystal particles by using two solution mixing based on the ternary phase diagram. J Cryst Growth. 2014;392:87–91.
   Web of Science ®Google Scholar
• Zhang S, Rasmuson ÅC. Thermodynamics and crystallization of the theophylline–glutaric acid cocrystal. Cryst. Growth Des. 2013;13(3):1153–1161.
   Web of Science ®Google Scholar
• Padrela L, Rodrigues MA, Velaga SP, et al. Formation of indomethacin-saccharin cocrystals using supercritical fluid technology. Eur J Pharm Sci. 2009;38(1):9–17.
   PubMed Web of Science ®Google Scholar
• Müllers KC, Paisana M, Wahl MA. Simultaneous formation and micronization of pharmaceutical cocrystals by rapid expansion of supercritical solutions (RESS). Pharm Res. 2015;32(2):702–713.
   PubMed Web of Science ®Google Scholar
• Neurohr C, Revelli AL, Billot P, et al. Naproxen-nicotinamide cocrystals produced by CO2 antisolvent. J Supercrit Fluids. 2013;83:78–85.
   Web of Science ®Google Scholar
• Tiago JM, Padrela L, Rodrigues MA, et al. Single-step co-crystallization and lipid dispersion by supercritical enhanced atomization. Cryst Growth Des. 2013;13(11):4940–4947.
   Web of Science ®Google Scholar
• Bolla G, Nangia A. Pharmaceutical cocrystals: walking the talk. Chem Commun (Camb). 2016;52(54):8342–8360.
   PubMed Web of Science ®Google Scholar
• Moradiya HG, Islam MT, Halsey S, et al. Continuous cocrystallisation of carbamazepine and trans-cinnamic acid via melt extrusion processing. CrystEngComm. 2014;16(17):3573–3583.
   Web of Science ®Google Scholar
• Fernandes GJ, Rathnanand M, Kulkarni V. Mechanochemical synthesis of carvedilol cocrystals utilizing hot melt extrusion technology. J Pharm Innov. 2019;14(4):373–381.
   Web of Science ®Google Scholar
• Srinivasan P. Investigation of theophylline nicotinamide pharmaceutical co-crystals utilizing hot melt extrusion; 2019. Electronic Theses and Dissertations. 1682. https://egrove.olemiss.edu/etd/1682
   Google Scholar
• Douroumis D, Ross SA, Nokhodchi A. Advanced methodologies for cocrystal synthesis. Adv Drug Deliv Rev. 2017;117:78–95.
   Web of Science ®Google Scholar
• Patil H, Tiwari RV, Repka MA. Hot-melt extrusion: from theory to application in pharmaceutical formulation. AAPS PharmSciTech. 2016;17(1):20–42.
   PubMed Web of Science ®Google Scholar
• Gajda M, Nartowski KP, Pluta J, et al. Continuous, one-step synthesis of pharmaceutical cocrystals via hot melt extrusion from neat to matrix-assisted processing – state of the art. Int J Pharm. 2019;558:426–440.
   PubMed Web of Science ®Google Scholar
• Paradkar A, Dhumal RS, Kelly AL, et al. Cocrystallization and simultaneous agglomeration using hot melt extrusion. Pharm Res. 2010;27(12):2725–2733.
   PubMed Web of Science ®Google Scholar
• Gajda M, Nartowski KP, Pluta J, et al. The role of the polymer matrix in solvent-free hot melt extrusion continuous process for mechanochemical synthesis of pharmaceutical cocrystal. Eur J Pharm Biopharm. 2018;131:48–59.
   PubMed Web of Science ®Google Scholar
• Gajda M, Nartowski KP, Pluta J, et al. Tuning the cocrystal yield in matrix-assisted cocrystallisation via hot melt extrusion: a case of theophylline-nicotinamide cocrystal. Int J Pharm. 2019;569:118579.
   PubMedGoogle Scholar
• Aher S, Dhumal R, Mahadik K, et al. Effect of cocrystallization techniques on compressional properties of caffeine/oxalic acid 2:1 cocrystal. Pharm Dev Technol. 2013;18(1):55–60.
   PubMed Web of Science ®Google Scholar
• Pindelska E, Sokal A, Kolodziejski W. Pharmaceutical cocrystals, salts and polymorphs: advanced characterization techniques. Adv Drug Deliv Rev. 2017;117:111–146.
   PubMed Web of Science ®Google Scholar
• Cerreia Vioglio P, Chierotti MR, Gobetto R. Pharmaceutical aspects of salt and cocrystal forms of APIs and characterization challenges. Adv Drug Deliv Rev. 2017;117:86–110.
   PubMed Web of Science ®Google Scholar
• Izutsu K, Koide T, Takata N, et al. Characterization and quality control of pharmaceutical cocrystals. Chem Pharm Bull. 2016;64(10):1421–1430.
   PubMed Web of Science ®Google Scholar
• Peltonen L. Practical guidelines for the characterization and quality control of pure drug nanoparticles and nano-cocrystals in the pharmaceutical industry. Adv Drug Deliv Rev. 2018;131:101–115.
   PubMed Web of Science ®Google Scholar
• Aitipamula S, Banerjee R, Bansal AK, et al. Polymorphs, salts, and cocrystals: what’s in a name? Crystal Growth Des. 2012;12(5):2147–2152.
   Web of Science ®Google Scholar
• Lu J. Crystallization and transformation of pharmaceutical solid forms. Afr J Pharm Pharmacol. 2012;6(9):581–591.
   Google Scholar
• Ali HRH, Alhalaweh A, Velaga SP. Vibrational spectroscopic investigation of polymorphs and cocrystals of indomethacin. Drug Dev Ind Pharm. 2013;39(5):625–634.
   PubMed Web of Science ®Google Scholar
• Tiţa B, Marian E, Fuliaş A, et al. Thermal stability of piroxicam. Part 2. Kinetic study of the active substance under isothermal conditions. J Therm Anal Calorim. 2013;112(1):367–374.
   Web of Science ®Google Scholar
• Silva Filho SF, Pereira AC, Sarraguça JMG, et al. Synthesis of a glibenclamide cocrystal: full spectroscopic and thermal characterization. J Pharm Sci. 2018;107(6):1597–1604.
   PubMed Web of Science ®Google Scholar
• Fernandes RP, do Nascimento ALCS, Carvalho ACS, et al. Mechanochemical synthesis, characterization, and thermal behavior of meloxicam cocrystals with salicylic acid, fumaric acid, and malic acid. J Therm Anal Calorim. 2019;138(1):765–777.
   Web of Science ®Google Scholar
• Dayo Owoyemi BC, Da Silva CCP, Souza MS, et al. Synthesis and structural characterization of four new pharmaceutical cocrystal forms. Cryst Growth Des. 2019;19(2):648–657.
   Web of Science ®Google Scholar
• Silva C, Souza MS, Dayo Owoyemi BC, et al. Fluconazole: synthesis and structural characterization of four new pharmaceutical cocrystal forms. ACS Publ. 2019;19(2):648–657.
   Google Scholar
• Arabiani MR, Lodagekar A, Yadav B, et al. Mechanochemical synthesis of brexpiprazole cocrystals to improve its pharmaceutical attributes. CrystEngComm. 2019;21(5):800–906.
   Web of Science ®Google Scholar
• Mashhadi SMA, Yufit D, Liu H, et al. Synthesis and structural characterization of cocrystals of isoniazid and cinnamic acid derivatives. J Mol Struct. 2020;1219:128621.
   Web of Science ®Google Scholar
• Maddileti D, Jayabun SK, Nangia A. Soluble cocrystals of the xanthine oxidase inhibitor febuxostat. Cryst Growth Des. 2013;13(7):3188–3196.
   Web of Science ®Google Scholar
• Latha MM, Novena LM, Athimoolam S, et al. Single crystal XRD, Hirshfeld surface, vibrational and thermal studies on a new zwitterionic co-crystal of vitaminB3 (nicotinic acid). J Mol Struct. 2020;1205:127578.
   Web of Science ®Google Scholar
• Padrela L, De Azevedo EG, Velaga SP. Powder X-ray diffraction method for the quantification of cocrystals in the crystallization mixture. Drug Dev Ind Pharm. 2012;38(8):923–929.
   PubMed Web of Science ®Google Scholar
• Butreddy A, Sarabu S, Bandari S, et al. Polymer-assisted aripiprazole − adipic acid cocrystals produced by hot melt extrusion techniques. Cryst Growth Des. 2020;20: 4335–4345.
   PubMed Web of Science ®Google Scholar
• Sopyan I, Fudholi A, Muchtaridi M, et al. Simvastatin-nicotinamide co-crystal: design, preparation and preliminary characterization. Trop J Pharm Res. 2017;16(2):297–303.
   Web of Science ®Google Scholar
• Seo JW, Hwang KM, Lee SH, et al. Preparation and characterization of adefovir dipivoxil-stearic acid cocrystal with enhanced physicochemical properties. Pharm Dev Technol. 2018;23(9):890–899.
   PubMed Web of Science ®Google Scholar
• Nijhawan M, Santhosh A, Babu PRS, et al. Solid state manipulation of lornoxicam for cocrystals—physicochemical characterization. Drug Dev Ind Pharm. 2014;40(9):1163–1172.
   PubMed Web of Science ®Google Scholar
• Gadade DD, Pekamwar SS. Pharmaceutical cocrystals: regulatory and strategic aspects, design and development. Adv Pharm Bull. 2016;6(4):479–494.
   PubMed Web of Science ®Google Scholar
• Shete AS, Yadav AV, Murthy MS. Evaluation of performance of co crystals of mefloquine hydrochloride in tablet dosage form. Drug Dev Ind Pharm. 2013;39(5):716–723.
   PubMed Web of Science ®Google Scholar
• Kim S, Li Z, Tseng YC, et al. Development and characterization of a cocrystal as a viable solid form for an active pharmaceutical ingredient. Org Process Res Dev. 2013;17(3):540–548.
   Web of Science ®Google Scholar
• Modi SR, Dantuluri AKR, Puri V, et al. Impact of crystal habit on biopharmaceutical performance of celecoxib. Cryst Growth Des. 2013;13(7):2824–2832.
   Web of Science ®Google Scholar
• Smith AJ, Kavuru P, Wojtas L, et al. Cocrystals of quercetin with improved solubility and oral bioavailability. Mol Pharm. 2011;8(5):1867–1876.
   PubMed Web of Science ®Google Scholar
• Titapiwatanakun V, Basit AW, Gaisford S. A new method for producing pharmaceutical co-crystals: laser irradiation of powder blends. Cryst Growth Des. 2016;16(6):3307–3312.
   Web of Science ®Google Scholar
• Urbanus J, Roelands CM, Mazurek J, et al. Electrochemically induced co-crystallization for product removal. CrystEngComm. 2011;13(8):2817–2819.
   Web of Science ®Google Scholar
• Ende DJ, Anderson SR, Salan JS. Development and scale-up of cocrystals using resonant acoustic mixing. Org Process Res Dev. 2014;18(2):331–341.
   Web of Science ®Google Scholar
• Patil SP, Modi SR, Bansal AK. Generation of 1:1 carbamazepine:nicotinamide cocrystals by spray drying. Eur J Pharm Sci. 2014;62:251–257.
   PubMed Web of Science ®Google Scholar
• Eddleston MD, Patel B, Day GM, et al. Cocrystallization by freeze-drying: preparation of novel multicomponent crystal forms. Cryst Growth Des. 2013;13(10):4599–4606.
   Web of Science ®Google Scholar
• Karashima M, Sano N, Yamamoto S, et al. Enhanced pulmonary absorption of poorly soluble itraconazole by micronized cocrystal dry powder formulations. Eur J Pharm Biopharm. 2017;115:65–72.
   PubMed Web of Science ®Google Scholar
• Martin F, Pop M, Kacso I, et al. Ketoconazole-p-aminobenzoic acid cocrystal: revival of an old drug by crystal engineering. Mol Pharm. 2020;17(3):919–932.
   PubMedGoogle Scholar
• Kimoto K, Yamamoto M, Karashima M, et al. Pharmaceutical cocrystal development of TAK-020 with enhanced oral absorption. Crystals. 2020;10(3):211.
   Web of Science ®Google Scholar
• He H, Zhang Q, Wang JR, et al. Structure, physicochemical properties and pharmacokinetics of resveratrol and piperine cocrystals. CrystEngComm. 2017;19(41):6154–6163.
   Web of Science ®Google Scholar
• Soliman II, Kandil SM, Abdou EM. Gabapentin-saccharin co-crystals with enhanced physicochemical properties and in vivo absorption formulated as oro-dispersible tablets. Pharm Dev Technol. 2020;25(2):227–236.
   PubMed Web of Science ®Google Scholar
• Chadha K, Karan M, Bhalla Y, et al. Cocrystals of hesperetin: structural, pharmacokinetic, and pharmacodynamic evaluation. Cryst Growth Des. 2017;17(5):2386–2405.
   Web of Science ®Google Scholar
• Xu J, Huang Y, Ruan S, et al. Cocrystals of isoliquiritigenin with enhanced pharmacokinetic performance. CrystEngComm. 2016;18(45):8776–8786.
   Web of Science ®Google Scholar
• He H, Huang Y, Zhang Q, et al. Zwitterionic cocrystals of flavonoids and proline: solid-state characterization, pharmaceutical properties, and pharmacokinetic performance. Cryst Growth Des. 2016;16(4):2348–2356.
   Web of Science ®Google Scholar
• Li W, Pi J, Zhang Y, et al. A strategy to improve the oral availability of baicalein: the baicalein-theophylline cocrystal. Fitoterapia. 2018;129(88):85–93.
   PubMedGoogle Scholar
• Haneef J, Chadha R. Sustainable synthesis of ambrisentan-syringic acid cocrystal: employing mechanochemistry in the development of novel pharmaceutical solid form. CrystEngComm. 2020;22(14):2507–2516.
   Web of Science ®Google Scholar
• Dai XL, Wu C, Li JH, et al. Modulating the solubility and pharmacokinetic properties of 5-fluorouracilviacocrystallization. CrystEngComm. 2020;22(21):3670–3682.
   Web of Science ®Google Scholar
• Wu N, Zhang Y, Ren J, et al. Preparation of quercetin-nicotinamide cocrystals and their evaluation under in vivo and in vitro conditions. RSC Adv. 2020;10(37):21852–21859.
   Web of Science ®Google Scholar
• Zhang Z, Yu N, Xue C, et al. Potential anti-tumor drug: co-crystal 5-fluorouracil-nicotinamide. ACS Omega. 2020;5(26):15777–15782.
   PubMed Web of Science ®Google Scholar
• Liu F, Jiang FB, Li YT, et al. Cocrystallization with syringic acid presents a new opportunity for effectively reducing the hepatotoxicity of isoniazid. Drug Dev Ind Pharm. 2020;46(6):988–995.
   PubMed Web of Science ®Google Scholar
• Thimmasetty J, Ghosh T, Nayak NS, et al. Oral bioavailability enhancement of paliperidone by the use of cocrystallization and precipitation inhibition. J Pharm Innov. 2020.DOI:10.1007/s12247-020-09428-2
   Google Scholar
• Madhuri G, Nagaraju R, Killari AKN. Enhancement of the physicochemical properties of poorly soluble lovastatin by co-crystallization techniques—in vivo studies. Indian J Pharm Sci. 2020;82(2):66–76.
   Web of Science ®Google Scholar
• Song Y, Wang LY, Liu F, et al. Simultaneously enhancing the: in vitro/in vivo performances of acetazolamide using proline as a zwitterionic coformer for cocrystallization. CrystEngComm. 2019;21(19):3064–3073.
   Web of Science ®Google Scholar
• Zhou F, Zhou J, Zhang H, et al. Structure determination and in vitro/vivo study on carbamazepine–naringenin (1:1) cocrystal. J Drug Deliv Sci Technol. 2019;54:101244.
   Web of Science ®Google Scholar
• Mohite R, Mehta P, Arulmozhi S, et al. Synthesis of fisetin co-crystals with caffeine and nicotinamide using the cooling crystallization technique: biopharmaceutical studies. New J Chem. 2019;43(34):13471–13479.
   Web of Science ®Google Scholar
• Kawakami K. Modification of physicochemical characteristics of active pharmaceutical ingredients and application of supersaturatable dosage forms for improving bioavailability of poorly absorbed drugs. Adv Drug Deliv Rev. 2012;64(6):480–495.
   PubMed Web of Science ®Google Scholar
• Srivastava D, Fatima Z, Kaur CD, et al. Pharmaceutical cocrystal: a novel approach to tailor the biopharmaceutical properties of a poorly water soluble drug. Recent Pat Drug Deliv Formul. 2019;13(1):62–69.
   PubMedGoogle Scholar
• Shan N, Perry ML, Weyna DR, et al. Impact of pharmaceutical cocrystals: the effects on drug pharmacokinetics. Expert Opin Drug Metab Toxicol. 2014;10(9):1255–1271.
   PubMed Web of Science ®Google Scholar
• Liu F, Wang LY, Yu MC, et al. A new cocrystal of isoniazid-quercetin with hepatoprotective effect: the design, structure, and in vitro/in vivo performance evaluation. Eur J Pharm Sci. 2020;144:105216.
   PubMed Web of Science ®Google Scholar
• Tomar S, Chakraborti S, Jindal A, et al. Cocrystals of diacerein: towards the development of improved biopharmaceutical parameters. Int J Pharm. 2020;574:118942.
   PubMedGoogle Scholar